The findings in the most recent Valisure petition are based on unproven, questionable methods applying unrealistic conditions which are inconsistent with the way Benzoyl Peroxide products would normally be stored.
In a December 2022 letter, the FDA highlighted multiple deficiencies in Valisure's analytical methods, stating that the lab should follow the same testing methods that drug manufacturers are required to use.
The Valisure petition statements are under question given their flawed analytics of testing Benzoyl Peroxide under excess storage conditions at high temperatures for prolonged periods of time which does not replicate consumer conditions of usual and normal use. Additionally, there may be a potential conflict of interest in the information presented by Valisure given a pending patent on a similar ingredient.
The FDA has made statements indicating that Benzoyl Peroxide is safe to use. OTC drug products such as anti-acne treatments are highly regulated by the FDA, which has reviewed and determined Benzoyl Peroxide as a safe and effective anti-acne ingredient. Benzoyl Peroxide should be stored properly in cool areas and out of direct sunlight.
Comments